Donald J Santel's Net Worth
$17.1 Million
Who is Donald J Santel?
Donald J Santel has an estimated net worth of $17.1 Million. This is based on reported shares across multiple companies, which include COTHERIX INC, HYPERION THERAPEUTICS INC, Oyster Point Pharma, Inc., Surrozen, Inc./DE, Aerovate Therapeutics, Inc., and Anthera Pharmaceuticals Inc.
SEC CIK
Donald J Santel's CIK is 0001293630
Past Insider Trading and Trends
2015 was Donald J Santel's most active year for acquiring shares with 5 total transactions. Donald J Santel's most active month to acquire stocks was the month of February. 2015 was Donald J Santel's most active year for disposing of shares, totalling 15 transactions. Donald J Santel's most active month to dispose stocks was the month of December. 2015 saw Donald J Santel paying a total of $675,572.68 for 402,057 shares, this is the most they've acquired in one year. In 2015 Donald J Santel cashed out on 1,374,978 shares for a total of $49,762,674.16, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
COTHERIX INC No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -72.03K |
$13.50 | -$972,445.50 |
0
|
Jan 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HYPERION THERAPEUTICS INC No price found
CEO & President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -358.40K |
$46.00 | -$16,486,492.00 |
0
|
May 7
| |||
Form 4
| +517.12% | 292.06K |
$2.31 | $675,572.68 | 348.54K |
May 1
| |||
Form 4
| +242.75% | 40K |
—
|
—
| 56.48K |
Feb 9
| |||
Form 4
| -10.93% | -2.02K |
$24.28 | -$49,094.16 | 16.48K |
Jan 2
| |||
Form 4
|
∞
| 18.5K |
—
|
—
| 18.5K |
Mar 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Oyster Point Pharma, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -13.69K |
—
|
—
|
0
|
Jan 3
| |||
Form 4
| +35.33% | 3.57K |
—
|
—
| 13.69K |
Jun 6
| |||
Form 4
|
∞
| 10.11K |
—
|
—
| 10.11K |
Jul 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Surrozen, Inc./DE (SRZN) Snapshot price: $9.3
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 30K |
—
|
—
| 30K |
Aug 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aerovate Therapeutics, Inc. (AVTE) Snapshot price: $20.3
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||